Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. This is a minor page metadata update and does not affect study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe study page no longer displays the banner about government funding and NIH operating status, including the guidance to check cc.nih.gov and opm.gov for updates.SummaryDifference0.4%

- Check42 days agoChange DetectedThe updated page shows only minor layout and wording adjustments without altering core study details, eligibility criteria, or reported results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference4%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion tag updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No changes to core content, pricing, stock, or time slot information.SummaryDifference0.2%

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.